The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpire Healthcare Regulatory News (SPI)

Share Price Information for Spire Healthcare (SPI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 247.00
Bid: 247.00
Ask: 248.00
Change: -0.50 (-0.20%)
Spread: 1.00 (0.405%)
Open: 250.00
High: 250.00
Low: 246.00
Prev. Close: 247.50
SPI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement in principle with NHS England

10 Jan 2022 07:00

RNS Number : 8485X
Spire Healthcare Group PLC
10 January 2022
 

Spire Healthcare Group plc

 

("Spire Healthcare", "the Company" or "the Group")

 

Agreement in principle with NHS England to provide further COVID-19 support

 

10 January 2022

 

Spire Healthcare Group plc (LSE: SPI), a leading UK independent hospital group, announces that, at the request of NHS England ("NHSE"), it has reached an agreement in principle to provide support to the NHS and its patients during the ongoing COVID-19 pandemic. This agreement follows detailed discussions with NHSE and other independent providers, in light of the uncertainties created by the Omicron variant.

 

While the final details of a new contract have yet to be agreed, it will operate on similar terms to the contract in place during Jan-Mar 2021 which was announced on 21 December 2020. The agreement in principle is for payment by activity based on NHS tariff, with minimum value underpins.

 

Work under the agreement in principle will commence on Monday 10 January and expire on 31 March 2022. There will be no extension or cancellation unless mutually agreed.

 

Under the agreement, Spire Healthcare, together with other independent providers, will continue to relieve pressure on NHS hospitals in England by treating NHS elective patients and providing urgent cancer work. The agreement will allow Spire Healthcare to continue to treat private patients, whilst supporting the NHS.

 

If required, subject to meeting agreed criteria, Spire Healthcare will grant NHSE access to 100% of its facilities and teams on a local, regional or national basis in the event of a surge of COVID-19 patients in NHS hospitals in England. If a Spire Healthcare hospital is in surge, Spire Healthcare will receive 100% cost recovery for its services.

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

- Ends -

 

For further information please contact:

 

Spire Healthcare

Angus Prentice - Interim Head of Investor Relations +44 (0)7974 982 512

 

Instinctif Partners

Damian Reece +44 (0)7931 598 593

Guy Scarborough +44 (0)7917 178 920

Jeremy Durrant +44 (0)7792 918 648

 

Registered Office and Head Office:

 

Spire Healthcare Group plc

3 Dorset Rise

London

EC4Y 8EN

Registered number 09084066

 

About Spire Healthcare

 

Spire Healthcare is a leading independent hospital group in the United Kingdom, with 40 private hospitals and eight clinics across England, Wales and Scotland.

 

Working in partnership with around 7,500 experienced consultants, Spire Healthcare delivered tailored, personalised care to almost 750,000 in-patients and daycase patients in 2020, and is the leading private provider, by volume, of knee and hip operations in the United Kingdom.

 

The Group's well-located and scalable hospitals have delivered successful and award-winning clinical outcomes, positioning the Group well with patients, consultants, the NHS, GPs and Private Medical Insurance ("PMI") providers. 90% of Spire Healthcare's hospitals are rated 'Good' or 'Outstanding' by the CQC (or the equivalent in Scotland and Wales).

 

Spire Healthcare treats patients through a variety of routes including PMI, Self-pay and the NHS, providing the Group with diversified access to the expected growth opportunities in the UK healthcare market, which faces significant supply challenges as a result of NHS budget constraints and increasing demand from a growing population with longer life expectancy.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGREASFNEDKAEFA
Date   Source Headline
22nd Apr 20247:00 amRNSMajor Contract Win with Spire Healthcare
17th Apr 20247:00 amRNSCapital Markets Event
4th Apr 202411:13 amRNSNotice of AGM
4th Apr 202410:35 amRNSBlock listing Interim Review
3rd Apr 20247:00 amRNSPortfolio management: Spire Tunbridge Wells
2nd Apr 20243:42 pmRNSTotal Voting Rights
28th Mar 20241:54 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSNotice of Capital Markets Event
15th Mar 202410:07 amRNSDirector/PDMR Shareholding
1st Mar 20244:35 pmRNSTotal Voting Rights
29th Feb 20247:00 amRNSCFO transition
29th Feb 20247:00 amRNSFinal Results
13th Feb 20247:31 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSTotal Voting Rights and Capital
29th Jan 20247:00 amRNSNotice of Preliminary Results
11th Jan 20243:18 pmRNSBlock listing Interim Review
1st Dec 20237:00 amRNSTotal Voting Rights and Capital
1st Nov 20239:47 amRNSTotal Voting Rights
20th Oct 202311:21 amRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSAcquisition of Vita Health Group
2nd Oct 20232:57 pmRNSTotal Voting Rights
2nd Oct 20239:19 amRNSBlock listing Interim Review
14th Sep 20237:00 amRNSHalf-year Report
1st Sep 20233:52 pmRNSTotal Voting Rights
11th Aug 20238:15 amRNSHolding(s) in Company
10th Aug 20237:00 amRNSNotice of Interim Results
1st Aug 20239:04 amRNSTotal Voting Rights
13th Jul 20233:15 pmRNSDirector Declaration
11th Jul 20237:49 amRNSBlock listing Interim Review
1st Jun 20239:12 amRNSTotal Voting Rights
11th May 20232:20 pmRNSResults of 2023 Annual General Meeting
11th May 20237:00 amRNSAGM Statement
12th Apr 20234:22 pmRNSDirector/PDMR Shareholding
3rd Apr 202312:04 pmRNSAnnual Financial Report
3rd Apr 20238:07 amRNSTotal Voting Rights
30th Mar 20233:18 pmRNSBlock listing Interim Review
30th Mar 20232:48 pmRNSDirector/PDMR Shareholding
16th Mar 202310:00 amRNSDirector/PDMR Shareholding
9th Mar 20239:18 amRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSFinal Results
28th Feb 20234:01 pmRNSDirector Declaration
9th Feb 20237:00 amRNSPreliminary Results Presentation – Change of Venue
1st Feb 202310:52 amRNSTotal Voting Rights
23rd Jan 20237:00 amRNSNotice of Preliminary Results
20th Jan 20239:30 amRNSDirector Declaration
12th Jan 20239:42 amRNSBlock listing Interim Review
3rd Jan 20232:00 pmRNSTotal Voting Rights
19th Dec 20227:00 amRNSAcquisition of The Doctors Clinic Group Limited
1st Dec 202210:02 amRNSTotal Voting Rights
1st Nov 20221:24 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.